COST-EFFECTIVENESS OF RITUXIMAB IN THE TREATMENT OF RA PATIENTS IN THE NETHERLANDS

被引：0
|
作者：
Diamantopoulos, A. [1 ]
Kievit, W. [2 ]
De Vries, R. [3 ]
Pompen, M. [3 ]
机构：
[1] Symmetron Ltd, Elstree, Herts, England
[2] Dutch Rheumatoid Arthritis Monitoring Register, Nijmegen, Netherlands
[3] Roche, Woerden, Netherlands
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.435
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A311 / A311
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness treatment with Rituximab in patients with rheumatoid arthritis in real life
    Maurizio Benucci
    Gianantonio Saviola
    Paola Baiardi
    Mariangela Manfredi
    Rheumatology International, 2011, 31 : 1465 - 1469
  • [2] Cost-effectiveness treatment with Rituximab in patients with rheumatoid arthritis in real life
    Benucci, Maurizio
    Saviola, Gianantonio
    Baiardi, Paola
    Manfredi, Mariangela
    RHEUMATOLOGY INTERNATIONAL, 2011, 31 (11) : 1465 - 1469
  • [3] Cost-effectiveness of fosavancet in the treatment of osteoporosis in the Netherlands
    Jansen, J. P.
    Shavit, O.
    Bergman, G.
    Sen, S. S.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S259 - S259
  • [4] COST-EFFECTIVENESS OF RITUXIMAB (MABTHERA) COMPARED WITH TNF INHIBITORS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS (RA) IN POLAND
    Plisko, R.
    Krzystek, J.
    Rys, P.
    Russel-Szymczyk, M.
    Szkultecka-Debek, M.
    Szamotulska, K.
    VALUE IN HEALTH, 2008, 11 (06) : A544 - A544
  • [5] Cost-effectiveness of prucalopride in the treatment of chronic constipation in the Netherlands
    Nuijten, Mark J. C.
    Dubois, Dominique J.
    Joseph, Alain
    Annemans, Lieven
    FRONTIERS IN PHARMACOLOGY, 2015, 6
  • [6] COST-EFFECTIVENESS OF CLADRIBINE TABLETS FOR TREATMENT OF RRMS IN THE NETHERLANDS
    de Francesco, M.
    Mahajan, K.
    Michels, R. E.
    Schiffers, K.
    Budhia, S.
    Harty, G.
    Krol, M.
    VALUE IN HEALTH, 2018, 21 : S339 - S340
  • [7] Cost-effectiveness of adalimumab (Humira™) in the treatment of US patients with rheumatoid arthritis (RA)
    Bansback, N
    Brennan, A
    Sengupta, N
    VALUE IN HEALTH, 2004, 7 (03) : 241 - 241
  • [8] COST-EFFECTIVENESS OF MAVACAMTEN FOR THE TREATMENT OF PATIENTS WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN THE NETHERLANDS
    Buisman, L.
    Treur, M.
    Verkaik, M.
    Van De Wetering, G.
    Pronk, L. M.
    Pompen, M.
    Hurst, M.
    VALUE IN HEALTH, 2023, 26 (12) : S110 - S110
  • [9] The cost-effectiveness of zemplar in the Netherlands
    Nuijten, MJ
    Siegert, C
    VALUE IN HEALTH, 2006, 9 (03) : A7 - A8
  • [10] Modelling of the cost-effectiveness of rituximab for treatment of rheumatoid arthritis in Italy
    De, VS
    Giuliani, G
    Diamantopoulos, A
    Brown, B
    Kielhorn, A
    VALUE IN HEALTH, 2006, 9 (03) : A26 - A26
12345